Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in Patients With r/r Neurological Autoimmune Diseases

Clinical trial NCT06939166 · RECRUITING

Trial details

NCT number: NCT06939166
Sponsor: Tianjin Huanhu Hospital
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Neuromyelitis Optica Spectrum Disorders Myasthenia Gravis Multiple Sclerosis Chronic Inflammatory Demyelinating Polyradiculoneuropathy Autoimmune Encephalitis

Start date: 2025-06-17
Primary completion: 2026-04-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.